Shalini Sharp
Chief Financial Officer, Agenus.
Companies
- Septerna, Inc.Board member Oct 24, 2024 to now1
- BeOne Medicines Ltd.Board member Oct 2, 2024 to now2
- Organon & Co.Board member May 17, 2021 to now3
- Neurocrine BiosciencesBoard member Feb 4, 2020 to now4
- Mirati Therapeutics, Inc.Board member Mar 30, 2021 to Jan 23, 20245
- Sutro BiopharmaBoard member Nov 13, 2018 to Jun 8, 20226
- Precision BioSciencesBoard member Mar 27, 2019 to May 12, 20217
- Nuvation Bio Inc.Board member Jun 30, 2020 to Feb 26, 20218
- Ultragenyx Pharmaceutical Inc.Officer Jan 30, 2014 to Oct 16, 20209
- Ultragenyx Pharmaceutical Inc.Chief financial officer Feb 3, 2014 to Aug 19, 202010
- AgenusBoard member Jun 18, 2012 to Jun 22, 201811
- AgenusChief financial officer Oct 5, 2006 to Apr 30, 201212
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSepterna, Inc., Board member
- 2SEC EDGARBeOne Medicines Ltd., Board member
- 3SEC EDGAROrganon & Co., Board member
- 4SEC EDGARNeurocrine Biosciences, Board member
- 5
- 6SEC EDGARSutro Biopharma, Board member
- 7SEC EDGARPrecision BioSciences, Board member
- 8SEC EDGARNuvation Bio Inc., Board member
- 9
- 10
- 11SEC EDGARAgenus, Board member
- 12SEC EDGARAgenus, Chief financial officer